This month, I'll be attending an
advanced homotoxicology seminar in Denver, where some of the most
skilled homotoxicologists and veterinarians in the country will be
presenting lectures and practical applications of the use of this
modality for the treatment of cancer and endocrine disease
(diabetes, thyroid disease, and adrenal disease). These diseases
represent some of the biggest challenges to veterinarians.
As vets, we all learn one of the
cardinal rules of medicine - "First do no harm" - but so many of us
seem to forget it when we are faced with an extremely ill pet and a
desperate owner. Often, treatments are prescribed with the goal of
extending a pet's life with little regard to how good the quality
of that life is going to be. We need to remember that pets live in
the here and now. They don't know that a treatment that makes them
feel terribly sick now might help them later - they just know that
they feel awful. They might not agree that developing a terrible,
untreatable bladder infection - or heart failure - or kidney
failure - from chemotherapy was a good trade-off for another month
of life. And, for living beings that are so highly tied to the
taste of their food as are our pets, is eating a horrible tasting
prescription diet that hasn't even been proven to work, really a
good idea in all cases of kidney, liver, and heart disease?
As veterinarians and as pet
owners, we need to look - really look - at what we are asking our
pets to tolerate, in the interests of extending their lives.
Therapies can help or hurt, depending on how they are applied, how
carefully they are monitored, and how carefully the known side
effects from such treatments are proactively recognized and
treated.
Newer therapies are being
developed all the time, that offer the advantages of fewer side
effects with greater health benefits. Homotoxicology is such a
therapy. I'll be taking to the Denver seminar some client files -
pets that have just been diagnosed with cancer and pets that have
some of the other diseases mentioned above. Next month, I'll be
reporting back what I have learned.